Apexian Pharmaceuticals, Inc. — Form D

Apexian Pharmaceuticals, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-05. The offering totals $1.5M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Mark R Kelly, PhDDirectorIndianapolis, IN
Homer R PearceDirectorIndianapolis, IN
Mark R Kelly, PhDExecutive OfficerIndianapolis, IN
Steve CarchediDirectorCambridge, MA
Steve CarchediExecutive OfficerCambridge, MA
Timothy R TichenorExecutive OfficerIndianapolis, IN
John R BarnardDirectorIndianapolis, IN
Mark R Kelley, PhDDirectorIndianapolis, IN
Martin R Haslanger, PhDDirectorIndianapolis, IN
Roger R MillerExecutive OfficerIndianapolis, IN
David R BroeckerDirectorIndianapolis, IN
David R BroeckerExecutive OfficerIndianapolis, IN
Richard R MessmannExecutive OfficerIndianapolis, IN
Homer R Pearce, PhDDirectorIndianapolis, IN
David BroeckerDirectorJeffersonville, IN
David BroeckerExecutive OfficerJeffersonville, IN
Mark Kelly, PhDDirectorIndianapolis, IN
Mark Kelly, PhDExecutive OfficerIndianapolis, IN
John BarnardDirectorIndianapolis, IN
Homer PearceDirectorIndianapolis, IN
Roger MillerExecutive OfficerIndianapolis, IN
Martin Haslanger, PhDDirectorIndianapolis, IN
Timothy J TichenorExecutive OfficerGrand Rapids, MI
Richard R Messman, MDExecutive OfficerIndianapolis, IN
John H BarnardDirectorIndianapolis, IN

Other filings by this issuer (6)

FiledFormOfferingSold
2019-03-25D$2.0M$150K
2018-07-11D—$2.8M
2016-02-16D$750K$750K
2015-06-24D$650K$275K
2013-06-20D/A$2.5M$2.5M
2012-10-29D$2.0M$2.0M

More